Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.
Morgan RJ Jr, et al. Among authors: tetef m.
Cancer Chemother Pharmacol. 2004 Oct;54(4):283-9. doi: 10.1007/s00280-004-0818-x. Epub 2004 Jun 4.
Cancer Chemother Pharmacol. 2004.
PMID: 15184995
Clinical Trial.